Volume 3; Issue 1

Main
Evidence-based Oncology
Volume 3; Issue 1

Evidence-based Oncology

Volume 3; Issue 1

1

EDITORIAL

Associate Professor Benjamin Djulbegovic, Dr Debbie Singh

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 48 KB

english, 2002

2

Docetaxel plus cisplatin or carboplatin is as effective, but may be safer and more practical than vinorelbine plus cisplatin for treating non-small cell lung cancer

T. Berghmans, J.P. Sculier

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 77 KB

english, 2002

3

Vigorous activity may be associated with a modest increase in the risk of ovarian cancer

Beverly Rockhill

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 85 KB

english, 2002

4

Adding interferon-alfa to radiation therapy and carmustine does not improve survival rates in people with high-grade glioma

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 84 KB

english, 2002

5

Letrozole improves survival compared with megestrol acetate among women with advanced breast cancer

Serban D. Costa, Manfred Kaufmann

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 86 KB

english, 2002

6

Tumor cell aneuploidy is associated with poorer survival than near-diploidy in people with resected non-small-cell lung cancer

Victor Cohen, Fadlo R. Khuri

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 78 KB

english, 2002

7

Individually optimized regimen of intravesical mitomycin C reduces superficial bladder tumor recurrence compared with a standard regimen

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 95 KB

english, 2002

8

Compared to tamoxifen, letrozole increases tumor response in post-menopausal women with estrogen-receptor-positive primary breast cancer

Visaharan Sivasubramaniam, Gary H. Lyman

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 77 KB

english, 2002

9

Seven years of tamoxifen no better than 5 years among women with estrogen receptor-positive breast cancer and negative axillary nodes

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 76 KB

english, 2002

10

The effects of adjuvant high-dose medroxyprogesterone acetate are dependent on the population subgroup among women with breast cancer

Charles L. Shapiro

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 87 KB

english, 2002

11

Women at higher risk of breast cancer are more likely to attend population-based breast screening programmes

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 53 KB

english, 2002

12

Pegylated liposmal doxorubicin prolongs survival compared to topotecan as second-line treatment in women with platinum-sensitive ovarian cancer

Paul J. Hoskins

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 109 KB

english, 2002

13

Pravastatin prolongs survival in people with advanced hepatocellular carcinoma

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 82 KB

english, 2002

14

LHRH agonists are more effective when combined with tamoxifen for advanced premenopausal breast cancer

N. Bundred, Andrew Wardley

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 81 KB

english, 2002

15

Routine long-term androgen suppression following standard radiotherapy improves disease-free survival in men with unfavourable-prognosis prostate cancer compared with relapse-initiated therapy

Pirkko Kellokumpu-Lehtinen, Tapio Tulijoki

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 86 KB

english, 2002

16

Compared to tamoxifen, letrozole increases tumor response in post-menopausal women with advanced breast cancer

Visaharan Sivasubramaniam, Gary H. Lyman

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 98 KB

english, 2002

17

Fluorouracil plus leucovorin improves survival compared with fluorouracil plus levamisole following curative resection of stage III colon cancer

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 103 KB

english, 2002

18

Gail et al risk prediction model adequately estimates breast cancer risk in groups of women but has lower accuracy for individual women

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 82 KB

english, 2002

19

Adding prolonged asparaginase therapy to standard treatment may improve event-free survival among children with acute lymphoblastic leukemia

Akinobu Matsuzaki

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 82 KB

english, 2002

20

Graft-vs-host disease: what is the evidence?

Donald R. Fleming

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 132 KB

english, 2002

21

Glossary of terms

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 65 KB

english, 2002

22

Table A. Levels of evidence and grades of recommendations

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 43 KB

english, 2002